sodium citrate and citric acid- sodium citrate and citric acid monohydrate solution
cardinal health - sodium citrate, unspecified form (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate 500 mg in 5 ml - sodium citrate and citric acid oral solution usp is an effective alkalinizing agent. it is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. this product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. sodium citrate and citric acid oral solution usp is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. this product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. patients on sodium-restricted diets or with s
sodium citrate and citric acid- sodium citrate and citric acid monohydrate solution
pharmaceutical associates, inc. - sodium citrate (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate 500 mg in 5 ml - sodium citrate and citric acid oral solution usp is an effective alkalinizing agent. it is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. this product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. sodium citrate and citric acid oral solution usp is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. this product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. patients on sodium-restricted diets or with s
anticoagulant sodium citrate- trisodium citrate dihydrate solution
csl plasma inc. - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - anticoagulant sodium citrate 4% w/v solution usp is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. [see dosage and administration (2).] do not infuse anticoagulant sodium citrate 4% w/v solution usp directly to the donor. anticoagulant sodium citrate 4% w/v solution usp has not been adequately studied in controlled clinical trials with specific populations.
microlax solution rectal
famar orleans - sodium citrate, sodium laurylsulfoacetate, sorbitol solution - solution rectal - 90mg/ml+ 9mg/ml+ 893mg/ml
microlax solution rectal
delpharm orleans - sodium citrate, sodium laurylsulfoacetate, sorbitol solution - solution rectal - 90mg/ml+ 9mg/ml+ 893mg/ml
microlax solution rectal
delpharm orleans - sodium citrate, sodium laurylsulfoacetate, sorbitol solution - solution rectal - 90mg/ml+ 9mg/ml+ 893mg/ml
microlax rectal solution sodium citrate 450mg/5ml sodium lauryl sulphoacetate 45mg/5ml
johnson & johnson (ireland) limited - sodium citrate; sodium lauryl sulfoacetate - rectal solution - 450 mg/ 5 ml +45 mg/5ml - enemas; laurilsulfate, incl. combinations
sodium citrate 0.3m oral solution
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - sodium citrate - oral solution - sodium citrate 2.647 g - blood substitutes and perfusion solutions
sodium citrate 0.3m oral solution
p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - sodium citrate - oral solution - sodium citrate 2.647/30 g/ml - blood substitutes and perfusion solutions
sodium citrate 4% w/v anticoagulant- trisodium citrate dihydrate injection, solution
terumo bct, ltd - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate 4% w/v anticoagulant solution is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures. [see dosage and administration (2).] do not infuse sodium citrate 4% w/v anticoagulant solution usp directly to the donor. sodium citrate 4% w/v anticoagulant solution usp has not been adequately studied in controlled clinical trials with specific populations.